Intravenous ibandronate in men with osteoporosis: An open pilot study over 2 years
In the treatment of osteoporosis, the tolerance of oral bisphosphonates is often low. The high potency of ibandronate allows iv bolus injections that can be repeated every 2 to 3 months. However, the best dose and time interval of the treatment with iv ibandronate is still debated. Efficacy of 2-mg...
Saved in:
Published in | Journal of endocrinological investigation Vol. 26; no. 8; pp. 728 - 732 |
---|---|
Main Authors | , , , , , |
Format | Journal Article |
Language | English |
Published |
Milano
Kurtis
01.08.2003
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Be the first to leave a comment!